On the public citation graph

Impact of Moderate-to-High-Suicide-Intent in Major Depressive Disorder: Patient Characteristics and Healthcare Resource Utilisation in England

https://doi.org/10.2139/ssrn.4181707
0 signed · 17 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s40273-021-01019-4openalex-extracted
The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
inferredcites →https://doi.org/10.1016/0021-9681(87)90171-8openalex-extracted
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
inferredcites →https://doi.org/10.1016/j.jad.2021.05.115openalex-extracted
Prevalence of suicidal ideation and planning in patients with major depressive disorder: A meta-analysis of observation studies
inferredcites →https://doi.org/10.1016/j.jpsychires.2021.05.026openalex-extracted
Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study
inferredcites →https://doi.org/10.1016/s0140-6736(15)00390-6openalex-extracted
Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition
inferredcites →https://doi.org/10.1016/s0140-6736(21)02143-7openalex-extracted
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
inferredcites →https://doi.org/10.1016/s2468-2667(21)00047-5openalex-extracted
Prevalence and variability of current depressive disorder in 27 European countries: a population-based study
inferredcites →https://doi.org/10.1017/s0033291721001549openalex-extracted
Suicide rates among people with serious mental illness: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1136/bmj.h517openalex-extracted
Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database
inferredcites →https://doi.org/10.1136/bmjopen-2015-008650openalex-extracted
Primary care consultation rates among people with and without severe mental illness: a UK cohort study using the Clinical Practice Research Datalink
inferredcites →https://doi.org/10.1177/0020764007082482openalex-extracted
Psychiatric Intensive Care Units: a Literature Review
inferredcites →https://doi.org/10.1177/070674371405900702openalex-extracted
Treatment-Resistant Depression in Primary Care across Canada
inferredcites →https://doi.org/10.1186/s12888-020-02758-yopenalex-extracted
Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform
inferredcites →https://doi.org/10.1371/journal.pone.0231700openalex-extracted
Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations
inferredcites →https://doi.org/10.2147/ndt.s204265openalex-extracted
The burden of suicidal ideation across Europe: a cross-sectional survey in five countries
inferredcites →https://doi.org/10.4088/jcp.v68n0713openalex-extracted
Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1101/2024.08.06.24311489openalex-snapshot
Is the United Kingdom (UK) medicines pricing policy failing patients? The impact of terminated National Institute for Health and Care Excellence (NICE) appraisals for multi-indication products on patients
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.